Even safety data on TB-500 (synthetic TB4) is relatively scarce, with only a few studies reporting the potential side effects of its systemic application: In a 2010 study in 10 participants, TB4 caused occasional mild to moderate symptoms like headache and dizziness but no serious reactions or toxicities, even at doses up to 1260mg, administered daily for up to two weeks
No cosmetic, dermatological, therapeutic, or regenerative claims are made or implied
BPC-157 is not a controlled substance in Canada, and it is not approved for human use
DexCom InvestorsDexcom FreeStyle Libre 3: Ensure patients are on current lots
FIGURE 3 Discussion ACI has been shown to regenerate new tissues, reduce pain, and increase joint function after cartilage injury
Understanding the complete list of injectable peptides helps you see the full scope of compounds that use this same approach